Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

NCT00972725 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

AIDS

Interventions

BIOLOGICAL: GSK Biologicals' HIV vaccine (732461)
DRUG: Chloroquine

Sponsor

GlaxoSmithKline